Back
April 22, 2023

VSS Scientific Updates During Pandemic Times #55

1. Cancer and heart disease vaccines ‘ready by end of the decade’?

Burton said: “We will have that vaccine and it will be highly effective, and it will save many hundreds of thousands, if not millions of lives. I think we will be able to offer personalized cancer vaccines against multiple different tumor types to people around the world.”
https://www.theguardian.com/society/2023/apr/07/cancer-and-heart-disease-vaccines-ready-by-end-of-the-decade
From Geert: “Yes, you all understood the title correctly: Vaccines causing heart disease and cancer (and even auto-immune disease as highlighted in the article) will be ‘ready by end of the decade’.
In fact, some of those are already up and running. ‘Yes’, not kidding, I am talking about the mRNA-based Covid-19 vaccines.
As a seasoned vaccinologist, I could never understand how one could possibly administer a vaccine delivering an antigen that you don’t control at all: neither in terms of its dosage or duration of expression, nor in terms of its distribution. Complete lack of control of these critical criteria should almost by definition make mRNA vaccines a complete NO GO from a vaccinology viewpoint. But as if these shortcomings weren’t already problematic enough, mRNA vaccines are highly likely to induce steric immune refocusing (SIR). In my new book: ‘The Inescapable Immune Escape Pandemic’ (drgeert.com), I describe this phenomenon and how mRNA vaccines are highly likely to trigger it. Unless the opposite can be proven, mRNA vaccines would therefore promote immune escape and sideline protection mechanisms conferred by cell-based innate immunity.
Whereas upon natural infection other viral proteins downregulate immune recognition of surface proteins responsible for viral infection (e.g., S protein in the case of SARS-CoV-2) at an early stage of infection, this is not the case when these proteins are expressed as a result of vaccine-mediated mRNA-transfection of target host cells! Hence, poorly functional immune responses are induced that basically hide immunodominant epitopes even before the latter can be recognized by the immune system of the vaccinee.
As we ‘ve seen too often in the past, human megalomania can never overcome the laws of biology. It seems like mankind got addicted to experimentation and empiricism even if that inevitably implies ‘learning the hard way’.

I am not saying we can never successfully intervene in pathogen-host interactions; however, as a general rule, one should always be very skeptical if people want to make you believe they have figured out an extremely smart approach to trick pathogenic agents. Ask them whether they fully understand the immune pathogenesis of the disease. If the answer is ‘No’, you know that what you’re going to get will be reminiscent of so many miserable HIV vaccine failures. It’s easy to spend millions of dollars and do more harm than good!

2. Startling Evidence Suggests BioNTech and Pfizer Falsified Key Data: Part 1

“Evidence has emerged casting serious doubt over the authenticity of tests carried out by BioNTech (Marketing Authorisation Holder) and Pfizer to prove the fidelity of their product by demonstrating that only the spike protein of SARS-CoV-2 is expressed in cells by the nucleoside-modified mRNA Pfizer-BioNTech Covid-19 vaccine (BNT162b2).”
https://www.trialsitenews.com/a/startling-evidence-suggests-biontech-and-pfizer-falsified-key-data-part-1-e2595e7f

3. Part 2: Startling Evidence Suggests BioNTech/Pfizer Falsified Key Data & Further Scandals

“This then begs the question: did BioNTech/Pfizer conduct a wilful cover-up of their ‘Western blot’ results by presenting manipulated versions (of automated Westerns) to the regulators? Perhaps, a copy and paste job for the FDA and manipulation of the saturation levels for the EMA? And more importantly: how did the regulators accept these ‘Western blots’ as the primary evidence for proving the fidelity and consistency of BioNTech and Pfizer’s product?”
https://soniaelijah.substack.com/p/part-2-startling-evidence-suggests

4. Strategies for the Management of Spike Protein-Related Pathology
“In the wake of the Covid-19 crisis, a need has arisen to prevent and treat two related conditions, Covid vaccine injury and long Covid, both of which have a significant vascular component. Therefore, the management of these conditions require the development of strategies to prevent or dissolve blood clots and restore circulatory health. This review summarizes the evidence on strategies that can be applied to treat both long and vaccine injuries based on similar mechanisms of action.”
https://www.preprints.org/manuscript/202303.0344/v1

5. Pfizer Entering the 'Most Important' 18-month Stretch in Company History, CEO Says
"Moving forward, Bourla expects Pfizer’s COVID business to continue generating significant sales, noting that the virus won’t go away anytime soon. COVID-19 infection “creates very short-lasting immunity,” the CEO said Monday, noting that people can “get the same strain after 6 months.” With this considered, Bourla said Pfizer’s scientists expect the disease to be around “for the years to come.”
https://www.fiercepharma.com/pharma/jpm23-pfizer-entering-most-important-18-month-stretch-company-history-ceo-says

6. The WHO Pandemic Treaty: Our fundamental freedoms at risk
If you think your individual freedom and that of your (grand)children is important, you may want to watch this.
https://tube.childrenshealthdefense.eu/w/4cdmQt7EaB4oNPACsE3G6e?start=32s

Support our work
DONATE
Subscribe to our Substack Newsletter

Geert Vanden Bossche received his DVM from the University of Ghent, Belgium, and his PhD degree in Virology from the University of Hohenheim, Germany. He held adjunct faculty appointments at universities in Belgium and Germany. After his career in Academia, Geert joined several vaccine companies (GSK Biologicals, Novartis Vaccines, Solvay Biologicals) to serve various roles in vaccine R&D as well as in late vaccine development.

Geert then moved on to join the Bill & Melinda Gates Foundation’s Global Health Discovery team in Seattle (USA) as Senior Program Officer; he then worked with the Global Alliance for Vaccines and Immunization (GAVI) in Geneva as Senior Ebola Program Manager. At GAVI he tracked efforts to develop an Ebola vaccine. He also represented GAVI in fora with other partners, including WHO, to review progress on the fight against Ebola and to build plans for global pandemic preparedness.

Back in 2015, Geert scrutinized and questioned the safety of the Ebola vaccine that was used in ring vaccination trials conducted by WHO in Guinea. His critical scientific analysis and report on the data published by WHO in the Lancet in 2015 was sent to all international health and regulatory authorities involved in the Ebola vaccination program. After working for GAVI, Geert joined the German Center for Infection Research in Cologne as Head of the Vaccine Development Office. He is at present primarily serving as a Biotech / Vaccine consultant while also conducting his own research on Natural Killer cell-based vaccines.

Email: info@voiceforscienceandsolidarity.org

Recent Posts
May 8, 2024

KEY MESSAGES from my book

Read
May 6, 2024

Training is gaining!

Read
May 1, 2024

Batwoman already warned of another coronavirus outbreak

Read
Voices for Science and solidarity, © 2023